Molibresib besylate
Molibresib besylate (GSK525762C) is a potent and selective BET bromodomain inhibitor studied for refractory hematologic cancers. It induces reactive oxygen species (ROS) and ATM activation, demonstrating antitumor activity in both in vitro and in vivo preclinical models.
Product Specifications
CAS Number
1895049-20-3
Product Name Alternative
BET, I-BET 762 besylate, GSK 525762C, EpigeneticReaderDomain, Epigenetic Reader Domain, Molibresib besylate, ROS
Field of Research
Epigenetics & Chromatin, Immunology & Inflammation
Purity
99.64% (May vary between batches)
Solubility
DMSO:20 mg/mL (34.36 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.44 mM)
Smiles
S (=O) (=O) (O) C1=CC=CC=C1.O (C) C=1C=C2C (N3C ([C@H] (CC (NCC) =O) N=C2C4=CC=C (Cl) C=C4) =NN=C3C) =CC1
Molecular Formula
C28H28ClN5O5S
Molecular Weight
582.07
Storage Conditions
-20°C
Notes
For research use only.
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
NNT1 (CLCF1) (NM_013246) Human Tagged ORF Clone Lentiviral Particle
Multiplex Assay Kit for Guanylate Binding Protein 6 (GBP6)